Search Tag: Poseida Therapeutics

Executive Health Management

Poseida-therapeutics-appoints-charles-m-baum-m-d-ph-d-to-board-of-directors

2022 18 May

Poseida Therapeutics, Inc. a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure announced the appointment of  Charles M. Baum , M.D., Ph.D., to its Board of Directors, effective  May 16, 2022 . Additionally, the Company announced the...Read more